ANDA 71742, held by Dava Pharms Inc. Clorazepate Dipotassium.
As of Nov 16, 2026, ANDA 71742 (Clorazepate Dipotassium), held by Dava Pharms Inc, was first approved by FDA on Dec 14, 1987, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 14, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Clorazepate Dipotassium3.75MG ยท capsule;oral | Clorazepate Dipotassium | Discontinued |
| Jul 2, 1993 | Supplement 2Labeling | Approved | None posted |
| Aug 23, 1989 | Supplement 1Labeling | Approved | None posted |
| Dec 14, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters